Majumder Sudip, Khamrui Susmita, Dasgupta Jhimli, Dattagupta Jiban K, Sen Udayaditya
Crystallography and Molecular Biology Division, Saha Institute of Nuclear Physics, Kolkata, India.
Biochim Biophys Acta. 2012 Jul;1824(7):882-90. doi: 10.1016/j.bbapap.2012.04.009. Epub 2012 May 1.
Canonical serine protease inhibitors interact with cognate enzymes through the P3-P2' region of the inhibitory loop while its scaffold hardly makes any contact. Neighboring scaffolding residues like Arginines or Asparagine shape-up the inhibitory loop and favor the resynthesis of cleaved scissile bond. However, role of remote scaffolding residues, which are not involved in religation, was not properly explored. Crystal structures of two engineered winged bean chymotrypsin inhibitor (WCI) complexed with Bovine trypsin (BPT) namely L65R-WCI:BPT and F64Y/L65R-WCI:BPT show that the inhibitory loop of these engineered inhibitors are recognized and rigidified properly at the enzyme active site like other strong trypsin inhibitors. Chimeric protein ETI(L)-WCI(S), having a loop of Erythrina caffra Trypsin Inhibitor, ETI on the scaffold of WCI, was previously shown to behave like substrate. Non-canonical structure of the inhibitory loop and its flexibility are attributed to the presence of smaller scaffolding residues which cannot act as barrier to the inhibitory loop like in ETI. Double mutant A76R/L115Y-(ETI(L)-WCI(S)), where the barrier is reintroduced on ETI(L)-WCI(S), shows regaining of inhibitory activity. The structure of A76R/L115Y-(ETI(L)-WCI(S)) along with L65R-WCI:BPT and F64Y/L65R-WCI:BPT demonstrate here that the lost canonical conformation of the inhibitory loop is fully restored and loop flexibility is dramatically reduced. Therefore, residues at the inhibitory loop interact with the enzyme playing the primary role in recognition and binding but scaffolding residues having no direct interaction with the enzyme are crucial for rigidification event and the inhibitory potency. B-factor analysis indicates that the amount of inhibitory loop rigidification varies between different inhibitor families.
典型的丝氨酸蛋白酶抑制剂通过抑制环的P3 - P2'区域与同源酶相互作用,而其支架几乎不发生任何接触。相邻的支架残基,如精氨酸或天冬酰胺,塑造了抑制环,并有利于裂解的可裂解键的重新合成。然而,未参与重新连接的远端支架残基的作用尚未得到充分研究。两种工程化的四棱豆胰凝乳蛋白酶抑制剂(WCI)与牛胰蛋白酶(BPT)复合的晶体结构,即L65R - WCI:BPT和F64Y/L65R - WCI:BPT,表明这些工程化抑制剂的抑制环在酶活性位点像其他强胰蛋白酶抑制剂一样被正确识别并刚性化。嵌合蛋白ETI(L)-WCI(S),其在WCI的支架上具有刺桐胰蛋白酶抑制剂ETI的环,先前已被证明表现得像底物。抑制环的非典型结构及其灵活性归因于较小的支架残基的存在,这些残基不像在ETI中那样能对抑制环起到屏障作用。双突变体A76R/L115Y-(ETI(L)-WCI(S)),其中在ETI(L)-WCI(S)上重新引入了屏障,显示出抑制活性的恢复。A76R/L115Y-(ETI(L)-WCI(S))的结构以及L65R - WCI:BPT和F64Y/L65R - WCI:BPT在此表明,抑制环失去的典型构象已完全恢复,并且环的灵活性显著降低。因此,抑制环上的残基与酶相互作用,在识别和结合中起主要作用,但与酶没有直接相互作用的支架残基对于刚性化事件和抑制效力至关重要。B因子分析表明,抑制环刚性化的程度在不同的抑制剂家族之间有所不同。